CARATOZZOLO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 1.303
AS - Asia 789
EU - Europa 665
SA - Sud America 148
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.923
Nazione #
US - Stati Uniti d'America 1.263
SG - Singapore 321
CN - Cina 222
IT - Italia 210
DE - Germania 131
BR - Brasile 129
HK - Hong Kong 91
FI - Finlandia 54
UA - Ucraina 53
GB - Regno Unito 47
RU - Federazione Russa 40
VN - Vietnam 35
TR - Turchia 30
CA - Canada 27
IN - India 26
PL - Polonia 25
FR - Francia 22
IE - Irlanda 21
NL - Olanda 20
BD - Bangladesh 18
ZA - Sudafrica 9
SE - Svezia 8
AR - Argentina 7
BE - Belgio 7
MX - Messico 7
CZ - Repubblica Ceca 6
ES - Italia 5
IQ - Iraq 5
IR - Iran 5
JP - Giappone 5
TW - Taiwan 5
VE - Venezuela 5
AT - Austria 4
JO - Giordania 4
LT - Lituania 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
AL - Albania 2
CI - Costa d'Avorio 2
CO - Colombia 2
ID - Indonesia 2
MA - Marocco 2
NP - Nepal 2
PK - Pakistan 2
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.923
Città #
Ashburn 161
Singapore 146
Fairfield 128
Hong Kong 91
Woodbridge 65
Houston 57
Beijing 53
Seattle 51
Wilmington 50
New York 47
Cambridge 45
Munich 45
Los Angeles 44
Jacksonville 43
Brescia 42
Ann Arbor 40
Chandler 36
Milan 33
Helsinki 31
Istanbul 25
Nanjing 24
Princeton 24
Dallas 23
Warsaw 23
Dublin 21
The Dalles 20
Turku 20
Dearborn 16
Redondo Beach 15
Chicago 14
Ho Chi Minh City 13
San Francisco 13
São Paulo 13
Denver 12
Des Moines 11
Moscow 11
Montreal 10
Mumbai 10
Buffalo 9
Hanoi 9
Nuremberg 9
Shanghai 9
Frankfurt am Main 8
Jinan 8
London 8
Brussels 7
Chennai 7
Orem 7
Santa Clara 7
Stockholm 7
Toronto 7
Charlotte 6
Düsseldorf 6
Poplar 6
Boardman 5
Castelli Calepio 5
Changsha 5
Elk Grove Village 5
Guangzhou 5
Nanchang 5
Ningbo 5
Phoenix 5
Rio de Janeiro 5
Salò 5
San Giuliano Terme 5
Taipei 5
Washington 5
Amman 4
Amsterdam 4
Ardabil 4
Boston 4
Hangzhou 4
Johannesburg 4
Kunming 4
Norwalk 4
San Diego 4
Tokyo 4
Venezia 4
Atlanta 3
Augusta 3
Baku 3
Belo Horizonte 3
Belém 3
Bologna 3
Brasília 3
Brno 3
Brooklyn 3
Caracas 3
Da Nang 3
Favaro Veneto 3
Fuzhou 3
Guarulhos 3
Hebei 3
Lancaster 3
Lodi 3
Mexico City 3
Olomouc 3
Ottawa 3
Portsmouth 3
Rende 3
Totale 1.821
Nome #
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 215
COVID-19 impact on consecutive neurological patients admitted to the emergency department 210
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 189
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 172
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 167
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 165
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 159
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 147
Dementia after Three Months and One Year from Stroke: New Onset or Previous Cognitive Impairment? 119
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 105
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 88
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 83
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 82
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 73
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 66
The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network 65
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 64
Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia 63
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 62
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 60
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 60
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 59
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 55
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 54
Cerebral Amyloid Angiopathy in Alzheimer Disease: A Comparison between Different Versions of the Boston Criteria 47
Photophobia and migraine outcome during treatment with galcanezumab 47
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination 46
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 45
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology 44
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison 43
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 40
“Real-world” eligibility for aducanumab depends on clinical setting and patients' journey 37
The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease 34
Totale 2.965
Categoria #
all - tutte 14.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 48 5 24 15 33 30 10
2021/2022118 6 21 1 4 1 7 10 10 11 7 12 28
2022/2023146 20 5 8 6 15 33 7 8 22 8 7 7
2023/2024178 15 3 24 9 6 39 4 7 33 4 5 29
2024/2025799 16 5 3 141 65 57 67 51 100 72 126 96
2025/2026923 155 190 119 235 193 31 0 0 0 0 0 0
Totale 2.965